Breaking News Instant updates and real-time market news.

TASR

TASER

$22.09

-0.4 (-1.78%)

05:35
10/14/16
10/14
05:35
10/14/16
05:35

TASER initiated with an Outperform at Imperial Capital

Imperial Capital analyst Jeff Kessler started TASER with an Outperform rating and $27 price target. The company's "unaided" brand awareness and "very high" market share provide "significant leading advantage" over competitors in non-lethal weaponry space, Kessler tells investors in a research note.

TASR TASER
$22.09

-0.4 (-1.78%)

10/06/16
JPMS
10/06/16
NO CHANGE
Target $31
JPMS
Overweight
NYPD contract fuels concerns, but TASER selloff overdone, says JPMorgan
JPMorgan analyst Mark Strouse notes that TASER's stock has declined significantly this week owing largely to the reported loss of the NYPD body-camera contract to a competitor. While the analyst sees this loss as somewhat of a surprise, he thinks the contract's pricing was the largest factor weighing on the stock. However, Strouse believes the NYPD contract pricing was a one-off occurrence. The analyst sees the selloff in TASER's shares as overdone and recommends investors add to positions. He reiterates an Overweight rating and $31 price target on the shares.
10/06/16
JPMS
10/06/16
NO CHANGE
JPMS
Overweight
TASER selloff overdone, says JPMorgan
10/05/16
OPCO
10/05/16
NO CHANGE
OPCO
Perform
TASER competitor deal with NYPD should not set any precedent, says Oppenheimer
Oppenheimer analyst Andrew Uerkwitz believes Vievu's body camera contract with NYPD could result in some pricing pressure over time but should not set any precedents. The analyst notes that it was expected that TASER "can't win them all," and points out that the economics of the deal are a "sober reminder" that storage costs are as key as service and functionality. Uerkwitz expects TASER to shift the conversation toward innovation, additional services/opportunities, and leverage going forward. He reiterates a Perform rating on TASER's shares.
10/03/16
KING
10/03/16
NO CHANGE
Target $32
KING
Buy
TASER 'had no choice but to walk away' from NYPD deal, says CL King
CL King analyst George Godfrey said that according to a source he spoke with the $6.4M police body camera contract awarded by the City of New York may include cameras for as many as 5,000 police officers. If that is correct, TASER had "no choice but to walk away" from this opportunity, but the company still has the opportunity to sell body cameras to the other approximately 29,000 NYC police officers, Godfrey tells investors. The firm keeps a Buy rating and $32 price target on TASER shares, which are down about 14% to $24.62 in early afternoon trading.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.